03:32 AM EDT, 08/22/2024 (MT Newswires) -- Michael J. LaBarre, Chief Technical Officer, Senior Vice President, on August 20, 2024, sold 20,000 shares in Halozyme Therapeutics ( HALO ) for $1,228,020. Following the Form 4 filing with the SEC, LaBarre has control over a total of 168,176 shares of the company, with 168,176 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1159036/000141588924021850/xslF345X05/form4-08212024_100827.xml

Price: 62.25, Change: +0.08, Percent Change: +0.13